Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 15 January, 2014

GlaxoSmithKline PLC

Replacement Director/PDMR Shareholding

RNS Number : 7652X
GlaxoSmithKline PLC
15 January 2014
 



This announcement replaces the original announcement released on 3 January 2014 at 9.43am (RNS No: 8550W).

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc (the Company).

 

On 31 December 2013, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and ADSs in the Company through the annual reinvestment of dividends paid throughout 2013; calculated using an average price of £16.073 per Ordinary Share and $53.170 per ADS:

 

Non-Executive Director

Ordinary Shares

No. of ADSs

Sir Christopher Gent

4,466.364

 

Prof Sir Roy Anderson

685.862      

 

Dr Stephanie Burns

 

538.531

Stacey Cartwright

125.504

 

Lynn Elsenhans

 

78.145

Judy Lewent

 

        80.720

Sir Deryck Maughan

 

1,379.853

Dr Daniel Podolsky

 

968.774

Tom de Swaan

998.268

 

Jing Ulrich

 

24.625

Hans Wijers

3.630

 

Sir Robert Wilson

1,032.435

 

 

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

Sonja Arsenić 

Corporate Secretariat

15 January 2014

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDMGMMVKKGDZM

a d v e r t i s e m e n t